The global transdermal skin patches market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). The growing funding and investments for drug development and new launches boost the growth of market growth. For instance, in September 2021, ImQuest Biosciences has announced the launch of an antiretroviral (ARV) transdermal delivery patch. Simialry, in Feb 2020, the US FDA approved the Contraceptive Patch known as Twirla Transdermal System by Agile Therapeutics Inc. Twirla (levonorgestrel and ethinly estradiol) is a combination of the female hormones progestin and estrogen which is used as a method of contraception for use in women of reproductive potential with a BMI less than 30 kg/m2 for whom a combined hormonal contraceptive is appropriate.
Get Free Sample link @ https://www.omrglobal.com/request-sample/transdermal-skin-patches-market
Clinical trials of various drugs are underway, and this would be a positive impact on the growth of the market in the future. With new systems in the transdermal drug delivery technique, there has been a continuous rise in the market. As transdermal patches offer many benefits over traditional drug delivery such as the pill, powder, or liquid medication. One of the most important and fundamental benefits of using patches is direct to bloodstreams delivery while bypassing the liver’s metabolic activity. This method of drug delivery is very much beneficial for the patients who are suffering from hepatic disorders as stress to the liver as it is simply bypassed. Transdermal patches can be designed to provide prolonged and controlled release of certain drugs which can be convenient for pain relief drugs, nicotine, and hormone products. For instance, the granisetron transdermal system is a transdermal patch used to treat chemotherapy-induced nausea and vomiting in a regulated way.
Full report of Transdermal Skin Patches Market available @ https://www.omrglobal.com/industry-reports/transdermal-skin-patches-market
Market Coverage
- Segment Covered-
- By Type
- By Application
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Land-. Novartis International AG, Teva Pharmaceuticals USA Inc., The 3M Co., Mylan N.V., Pfizer Inc., and many more.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How does COVID-19 impact the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Transdermal Skin Patches Market Report by Segment
By Type
- Single-Layer Drug-in-Adhesive
- Multi-layer Drug-in-Adhesive
- Matrix
- Others
By Applications
- Pain Relief
- Smoking Reduction & Cessation Aid
- Overactive Bladder
- Hormonal Therapy
- Others
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/transdermal-skin-patches-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
